Jma Heart Health Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-05-2024
- Paid Up Capital ₹ 0.10 M
as on 25-05-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 83.39%
(FY 2022)
- Profit 384.88%
(FY 2022)
- Ebitda 2138.07%
(FY 2022)
- Net Worth 45.09%
(FY 2022)
- Total Assets 68.31%
(FY 2022)
About Jma Heart Health
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bimal Chhajer and Aditya Sethi serve as directors at the Company.
- CIN/LLPIN
U85100DL2010PTC202849
- Company No.
202849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jma Heart Health Private Limited offer?
Jma Heart Health Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Health Supplement.
Who are the key members and board of directors at Jma Heart Health?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bimal Chhajer | Director | 29-Nov-2022 | Current |
Aditya Sethi | Director | 23-Aug-2011 | Current |
Financial Performance of Jma Heart Health.
Jma Heart Health Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 83.39% increase. The company also saw a substantial improvement in profitability, with a 384.88% increase in profit. The company's net worth Soared by an impressive increase of 45.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Jma Heart Health?
Unlock access to Jma Heart Health's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Saaol Infotech Private LimitedActive 1 year 5 months
Bimal Chhajer and Aditya Sethi are mutual person
- Saaol Pharma Private LimitedActive 10 years 3 months
Bimal Chhajer and Aditya Sethi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jma Heart Health?
Unlock and access historical data on people associated with Jma Heart Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jma Heart Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jma Heart Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.